Mark C. Grier
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Escherichia coli research studies
- Vibrio bacteria research studies
Papers in
-
- Bacterial biofilms and quorum sensing 2
-
- Antibiotic Resistance in Bacteria 4
- Co-authors
- Anu Mahadevan (3 shared papers)Victoria J. Bartlett (3 shared papers)Stuart B. Levy (3 shared papers)Michael N. Alekshun (3 shared papers)Raj K. Razdan (2 shared papers)Graeme Griffin (2 shared papers)Billy R. Martin (2 shared papers)Atul Kumar Verma (2 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Medicinal Chemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Clinical Investigation (1 paper)Pharmacology Biochemistry and Behavior (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Mark C. Grier
11 papers receiving 330 citations
Peers
Comparison fields: 5 of 64
- Molecular Medicine 64
- Endocrinology 48
- Pharmacology 146
- Toxicology 24
- Cellular and Molecular Neuroscience 114
Countries citing papers authored by Mark C. Grier
This map shows the geographic impact of Mark C. Grier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Grier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Grier more than expected).
Fields of papers citing papers by Mark C. Grier
This network shows the impact of papers produced by Mark C. Grier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Grier. The network helps show where Mark C. Grier may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark C. Grier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 74 | |
| 2 | 2009 | 53 | |
| 3 | 2007 | 46 | |
| 4 | 2001 | 44 | |
| 5 | 2002 | 40 | |
| 6 | 2010 | 33 | |
| 7 | 2022 | 22 | |
| 8 | 2009 | 20 | |
| 9 | 2022 | 7 | |
| 10 | 2024 | 3 | |
| 11 | 2020 | 3 |
About Mark C. Grier
Mark C. Grier is a scholar working on Molecular Biology, Molecular Medicine, Genetics, Pharmacology and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 345 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Bacterial Genetics and Biotechnology (3 papers), Cannabis and Cannabinoid Research (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Bacterial biofilms and quorum sensing (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and interferon and immune responses (1 paper). The work is most often cited by research in Molecular Medicine (64 citations), Endocrinology (48 citations), Pharmacology (146 citations), Toxicology (24 citations) and Cellular and Molecular Neuroscience (114 citations). Mark C. Grier has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Anu Mahadevan, Victoria J. Bartlett, Stuart B. Levy, Michael N. Alekshun, Raj K. Razdan, Graeme Griffin, Billy R. Martin, Atul Kumar Verma, Lynne Garrity-Ryan and Sébastien Tanaka. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Clinical Investigation and Pharmacology Biochemistry and Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.